Page results
-
Information on contrast agents for X-ray, fluoroscopy, CT and angiography examinations at NHNN
-
UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
-
The Clinical and Research Informatics Unit at UCLH consists of a team of clinicians, researchers, software developers, business intelligence analysts and data scientists working together to develop a robust environment for the analysis of clinical data.
-
UCLH continues to achieve excellent results in the National Inpatient Survey. In 2021 patients rated their overall care as 8.5 out of 10 which is the top score in London and the second best in the Shelford Group.
-
The Royal Parks Half Marathon makes a spectacular return this weekend.
-
It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.
-
A world-first treatment for Creutzfeldt-Jakob disease (CJD) has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.
File results
-
FOI/2022/0169 - Strategic workforce plan for recruitment and retention of Allied Health Professions
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients